| Cell line name | NK-92CI | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | NK-92 ci; NK92CI; NK-92 transfected with pCEP4-LTR-hIL2 | ||||||||||||||||||
| Accession | CVCL_U271 | ||||||||||||||||||
| Resource Identification Initiative | To cite this cell line use: NK-92CI (RRID:CVCL_U271) | ||||||||||||||||||
| Comments | Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6672. Transfected with: HGNC; 6001; IL2. Caution: NantKwest exclusively owns, controls and distributes this cell line. Derived from sampling site: Peripheral blood. Cell type=Natural killer cell. | ||||||||||||||||||
| Disease | Natural killer cell lymphoblastic leukemia/lymphoma (NCIt: C82217) | ||||||||||||||||||
| Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
| ||||||||||||||||||
| Hierarchy | Parent: CVCL_2142 (NK-92) | ||||||||||||||||||
| Sex of cell | Male | ||||||||||||||||||
| Age at sampling | 50Y | ||||||||||||||||||
| Category | Cancer cell line | ||||||||||||||||||
| STR profile | Source(s): ATCC Markers:
Run an STR similarity search on this cell line | ||||||||||||||||||
| Publications | PubMed=10365666; DOI=10.1089/10430349950018030 Patent=US8034332 | ||||||||||||||||||
| Cross-references | |||||||||||||||||||
| Cell line collections | ATCC; CRL-2409 - Discontinued | ||||||||||||||||||
| Biological sample resources | BioSample; SAMN03471837 | ||||||||||||||||||
| Encyclopedic resources | Wikidata; Q54930657 | ||||||||||||||||||
| Entry history | |||||||||||||||||||
| Entry creation | 03-Feb-2014 | ||||||||||||||||||
| Last entry update | 16-Dec-2021 | ||||||||||||||||||
| Version number | 10 | ||||||||||||||||||